Genetic and biochemical characterization of dTOR, the Drosophila homolog of the target of rapamycin

  1. Sean Oldham1,3,
  2. Jacques Montagne2,3,
  3. Thomas Radimerski2,
  4. George Thomas2, and
  5. Ernst Hafen1,4
  1. 1Zoologisches Institut, Universität Zürich, 8057 Zürich, Switzerland; 2Friedrich Miescher Institute, 4058 Basel, Switzerland

Abstract

The adaptation of growth in response to nutritional changes is essential for the proper development of all organisms. Here we describe the identification of the Drosophila homolog of the target of rapamycin (TOR), a candidate effector for nutritional sensing. Genetic and biochemical analyses indicate that dTOR impinges on the insulin signaling pathway by autonomously affecting growth through modulating the activity of dS6K. However, in contrast to other components in the insulin signaling pathway, partial loss of dTOR function preferentially reduces growth of the endoreplicating tissues. These results are consistent with dTOR residing on a parallel amino acid sensing pathway.

Keywords

Footnotes

  • 3 These authors contributed equally to this work.

  • 4 Corresponding author.

  • E-MAIL hafen{at}zool.unizh.ch; FAX 41-1-635-68-20.

  • Article and publication are at www.genesdev.org/cgi/doi/10.1101/gad.845700.

    • Received July 17, 2000.
    • Accepted September 21, 2000.
| Table of Contents

Life Science Alliance